In lung cancer studies (Figure 2B), Samulin Erdem et al. [41] screened tumoral and normal lung tissue from 233 NSCLC patients for MKK3 and MAPK-activated kinase 2 (MK2) genes copy number alterations (CNAs). This evidence concerns the gene MAP2K3 and lung carcinoma.